
Developer of mRNA-molecules for therapeutic and prophylactic vaccines. The company has developed RNAdjuvant that enhances the immune response to a large number of different vaccines, including protein and peptide-based vaccines, without toxic effects.

Tell CureVac you're interested in working at the company, while keeping your personal identity anonymous. Comparably will give CureVac the opportunity to hire you. When there's a job opening that's a fit we'll make the match happen.
| 0% | Promoters |
|---|---|
| 100% | Passives |
| 0% | Detractors |
Send them an invite to rate the company culture.